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Abstract
The Brazilian Amazon is a hypo-endemic malaria region with nearly 300,000 cases each year. A variety of genetic
polymorphisms, particularly in erythrocyte receptors and immune response related genes, have been described to be
associated with susceptibility and resistance to malaria. In order to identify polymorphisms that might be associated with
malaria clinical outcomes in a Brazilian Amazonian population, sixty-four human single nucleotide polymorphisms in 37
genes were analyzed using a Sequenom massARRAY iPLEX platform. A total of 648 individuals from two malaria endemic
areas were studied, including 535 malaria cases (113 individuals with clinical mild malaria, 122 individuals with
asymptomatic infection and 300 individuals with history of previous mild malaria) and 113 health controls with no history of
malaria. The data revealed significant associations (p,0.003) between one SNP in the IL10 gene (rs1800896) and one SNP in
the TLR4 gene (rs4986790) with reduced risk for clinical malaria, one SNP in the IRF1 gene (rs2706384) with increased risk for
clinical malaria, one SNP in the LTA gene (rs909253) with protection from clinical malaria and one SNP in the TNF gene
(RS1800750) associated with susceptibility to clinical malaria. Also, a new association was found between a SNP in the CTL4
gene (rs2242665), located at the major histocompatibility complex III region, and reduced risk for clinical malaria. This study
represents the first association study from an Amazonian population involving a large number of host genetic
polymorphisms with susceptibility or resistance to Plasmodium infection and malaria outcomes. Further studies should
include a larger number of individuals, refined parameters and a fine-scale map obtained through DNA sequencing to
increase the knowledge of the Amazonian population genetic diversity.
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Introduction
Malaria is a life-threatening parasitic disease transmitted by
mosquitoes. Despite major efforts aimed at controlling the spread
and impact of the disease, it still persists as a major health burden,
being responsible for over a million deaths each year, mainly
children in Sub-Saharan Africa. In Brazil, there were over 300,000
recorded cases of malaria in 2010, almost exclusively (99.8% of the
cases) restricted to the Amazon Basin region [1].
Malaria is a complex disease with many genetic and environ-
mental determinants influencing the observed variation in
response to infection, progression and severity. Several factors
important for these different phenotypes include the parasite
genetic make-up and host age, state of immunity and genetic
background [2]. Resistance involves genetically-based and cell-
mediated immunological mechanisms, including the production of
specific antibodies that are main actors in the acquired immune
response [3], thereby reducing the severity of symptoms and
mortality. Resistance mechanisms have been described for both
the liver and blood stages of the parasite in the host [4].
Significant associations have been described between malaria
and a variety of host genetic polymorphisms that occur in
erythrocytes and cells of the immune system. The different
geographic distributions of sickle-cell disease, a-thalassemia,
glucose-6-phosphate dehydrogenase (G6PD), southeast asian
ovalocytosis and the Duffy-negative blood group are examples of
the general principle that different populations have selected
different genetic variants to protect against Plasmodium infection
(see [5,6,7] for reviews). The sickle-cell trait (HbS) [8], G6PD
(reviewed in [9]), and ABO blood group [10], are amongst a
number of host genes with polymorphisms found to reduce the risk
of severe malaria. Some genes relevant to immunity and
inflammation, such as the tumor necrosis factor (TNF) within
the MHC class III region, (reviewed in [11]), Toll-like receptors
(TLR-4, TLR-9) [12,13], CD40 ligand (CD40L) [14], interferon
gamma (IFN-c) (reviewed in [15]), and the nitric oxide synthase
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36692type 2 (NOS2A) genes (reviewed in [16]) have also been associated
with severe malaria.
Previous genetic studies in Brazilian Amazonian populations
have demonstrated different malaria protective effects from blood-
related polymorphisms (e.g. Duffy, ABO, Rh, MNSs and Kell
systems [17,18,19,20]), erythrocyte enzymes (G6PD [18]), recep-
tors (CR-1, complement receptor 1) [20,21], and polymorphisms
which play a critical role in the early innate immune response to
invading pathogens (e.g. TLRs [20,22]). Association of Duffy
blood group gene polymorphisms and susceptibility to P. vivax
malaria has been observed in five endemic states of the Brazilian
Amazon [17,18,19]. Variants in the TLRs associated with clinical
outcomes of malaria have been reported [20,22]. In particular, a
study across three areas of the Amazon basin found significant
associations between TLR-1 and TLR-6 variants with mild
malaria, whereas TLR-9 variants were associated with high
parasitemia [22]. No association was found between TLR-4
polymorphisms and mild malaria [22]. These results are in
agreement with previous studies that found no association between
TRL-4 and protection to mild malaria in a community in the
Baixo Amazonas region in the state of Para ´ [20]. Recent studies
have also shown a possible association between CR1-polymor-
phisms and susceptibility to P. falciparum infection in individuals
from an endemic area in the state of Amazonas [21]. However, in
the state of Para ´, no correlation was observed between CR-1 with
resistance to P. falciparum infections [20]. It has been reported that
the regulation of IL-10 levels, an anti- inflammatory cytokine, in
P. vivax infected patients may be unaltered by polymorphism in the
promoter region of IL-10 gene [23].
Here, we investigated the association of a larger number of host
candidate genes polymorphisms with susceptibility/resistance to
Plasmodium infection with clinical (mild) malaria in a population of
the Brazilian Amazon. We genotyped 64 single nucleotide
polymorphisms (SNPs) in 37 human host genes, including loci
related with erythrocytes receptors and immune response. Our
study is the first to comprehensively survey important malaria
candidate polymorphisms (including HbS and ABO) in a Brazilian
population from the Medium Negro River Basin in the Amazon.
This setting provided an excellent field to test hypotheses on the
generalization of established malaria-genetic associations, partic-
ularly for low endemic areas. It also provided a mean to find other
associations related to either different mechanisms or by linkage
disequilibrium with putative markers associated with susceptibil-
ity/resistance to Plasmodium infection [18].
Materials and Methods
Ethics Statement
Approval for the recruitment of participants, collection of blood
samples, DNA preparation and DNA genotyping was provided by
the relevant research ethics committee (Oswaldo Cruz Foundation
- protocol number 360/06) and an informed consent was obtained
from each participant.
Study Participants
Potential participants were engaged between January 2002 and
October 2006 from an ongoing epidemiological study of malaria
in the cities of Barcelos (n=596) and Santa Isabel do Rio Negro
(n=52), which are 350 km apart. The municipalities are located
within the Negro river micro region in the state of Amazonas and
display similar demographics. In 2006, the Annual Parasite Index
(API) was 264.4 cases per 1000 inhabitants in Barcelos [24] and
127.2 cases per in Santa Isabel do Rio Negro [25]. The mean
number of previous malaria episodes was 5.54610.52 in Barcelos
and 2.3261.33 in Santa Isabel. These differences were not
statistically significant (p=0.053). Greater details of social,
demographic and malaria data for the populations studied can
be found elsewhere [25,26].
The individuals included in this study had lived in the study area
for at least five year with similar social and genetic backgrounds.
The population of both municipalities is predominantly of
Amerindian descent from Tukano-Oriental speaking societies
[25,27,28]. Individuals were recruited during consultations for
malaria symptoms at the health service centers in both cities. For
each malaria case identified, a field team was dispatched to
perform an active search of the patient’s house and neighboring
houses. Healthy controls, asymptomatic infected individuals and
individuals with a previous malaria history, but not infected at the
moment of the study, were recruited during these active searches.
A previous history of malaria in uninfected individuals and healthy
controls was verified using reviews of health service charts from
each municipality. Persons who had used anti-malarial drugs
30 days before the recruitment day were excluded. The partici-
pants had a median age of ,19 years (malaria cases: median 18.0,
range 1.0–88.0; controls 19.0, 3.0–72.0), and 48.5% were males
(malaria cases: 283, 53.7%, controls: 31, 28.4%) (see Table 1).
Cases Definitions and Parasite Identification
Three definitions of malaria cases were used for the association
analysis: clinical malaria (mild, n=113), asymptomatic infected
individuals (n=122) and individuals with a previous history of
mild malaria (non-asymptomatic infection), but not infected at the
moment of blood collection (n=300). Clinical malaria was defined
in accordance to the guidelines of the World Health Organization
(WHO) for the American region and the Brazilian National
Malaria Control Programme (PNCM) including symptoms asso-
ciated to malaria (i.e., fever, chills or diaphoresis) and a positive
thick smear or rapid diagnostic test (RDT). Asymptomatic
Plasmodium-infected cases were defined as an individual without
symptoms for malaria within 30 days before or after the blood
collection, but with a positive thick smear and/or PCR, following
the recommendations of the Brazilian consensus group for studies
of asymptomatic individuals.
For each sample collected, a thick smear was prepared and
stained with Giemsa using the National Guidelines that was
examined by a certified expert using 200 microscope fields under
immersion oil. All positive samples were confirmed by another
individual blinded to the previous results and the infecting
Plasmodium species was identified by PCR according to published
protocols [17]. There was an even balance between P. falciparum
and P.vivax (Table 1).
Sample Preparation and Genotyping
The sample collection consisted of 535 cases (Barcelos n=494,
Santa Isabel n=41) and 113 healthy controls with no previous
history of malaria (Barcelos n=102, Santa Isabel n=11). DNA
samples were prepared by extraction from 300 ml of total blood
using a commercial kit following the manufacturer’s protocol
(PromegaH). Genomic DNA samples underwent whole genome
amplification by Primer Extension Pre-amplification (PEP) before
genotyping on a SequenomH MassArray genotyping platform
(http://www.sequenom.com) [29,30]. All samples underwent
genotyping on the same instrument resulting in low rates of
missing genotyping data. Sixty-four malaria candidate SNPs were
genotyped, including: Haemoglobin variant S (HbS) (rs334), and
an ABO blood group SNP that defines groups B and non-B
(rs8176746). The full list can be found in Table S1.
Candidate Malaria SNPs in a Brazilian Population
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Association studies were performed comparing different groups:
a) any_malaria group (clinical malaria patients, asymptomatic
infected individuals, and individuals with a previous history of
malaria) with the never_malaria group (control); b) clinical_malaria
group (current or previous mild malaria) with the never_malaria
group; c) asymptomatic infection group with the never_malaria group
and d) clinical_malaria group (current or previous mild malaria) with
asymptomatic infection group.
Genotypic deviations from the Hardy-Weinberg equilibrium
(HWE) were assessed using a chi-square statistical test. SNPs were
excluded from the analysis if there was at least 10% of the
genotype calls missing or a significant deviation from the HWE
(p,0.0001). A case-control association analysis using SNP alleles
and genotypes was undertaken by logistic regression and included
site (Barcelos or Santa Isabel do Rio Negro) and gender as
covariates. In this approach, the SNP of interest was modeled
assuming several related genotypic mechanisms (additive, domi-
nant, recessive, heterozygous advantage and general models) and
the minimum P-values from these correlated tests are reported.
Haplotypes were estimated using an expectation-maximization
algorithm [31], and score tests [32] were applied to assess the level
of evidence for both global and individual haplotype associations
with malaria. Linkage disequilibrium was estimated using the
pairwise-SNP r
2 and D-prime metrics.
Population structure or differences in allele frequencies between
sub-populations can lead to false positive associations. Differences
in allele frequencies were estimated between Barcelos and Santa
Isabel do Rio Negro using an Fst metric [33], where values close to
zero imply no difference, and values close to one imply complete
differentiation between locations.
Statistical analysis of SNPs on the X chromosome was
performed for each gender separately and, where applicable, the
results were pooled using meta-analytic techniques. All analyses
were performed using the R statistical package (http://www.r-
project.org). Performing multiple statistical tests lead to an
inflation in the occurrence of false positives and, by using a
permutation approach that accounted for correlation between
markers and tests, the estimated p-value cut-off of 0.003 was
considered statistically significant.
Results
Overall, nine SNPs were excluded from the analysis because
there was either a minor allele frequency of less than 1%
(rs33950507, rs2227507, rs12720463, rs9282799, rs8386,
rs5743809, hCD36_G1439C) or due to a high rate of missing
genotype calls (rs7935564, rs20541). Figure 1 shows the minimum
p-values from the genotypic tests applied to the autosomal SNPs.
There were five significant results for those with any_malaria
versus never_malaria group: rs1800896– IL10-1082 (OR: 0.528, CI:
0.360–0.774; P=0.0014), rs2706384 - IRF1 (OR: 1.881, 95% CI:
1.298–2.724; P=0.0005), rs2242665 - CTL4 (OR: 0.595, 95%
CI: 0.434–0.816; P=0.0012), rs4986790 - TLR4 (OR: 0.274,
95% CI: 0.124–0.604; P=0.0014) and rs909253 - LTA+252 (OR:
0.343, 95% CI: 0.182–0.647; P=0.0009) (see Table 2). Four of
these SNPs were also significant when analyzing clinical_malaria
versus never_malaria group: rs2706384 - IRF1 (OR: 2.023, 95% CI:
1.371–2.987; P=0.0002), rs2242665 - CTL4 (OR: 0.564, 95%
CI: 0.406–0.784; P=0.0006), rs4986790 - TLR4 (OR: 0.271,
95% CI: 0.116–0.633; P=0.002) and rs909253 - LTA+252 (OR:
0.366, 95% CI: 0.192–0.699; P=0.001). When analyzing
clinical_malaria versus asymptomatic infection group, associations
were observed with the TNF-376 promoter SNP (rs1800750,
OR:0.086, 95% CI: 0.016–0.473; P=0.0026), previously associ-
ated in a number of other malaria studies. (see [11] for a review).
The LTA and IL10 SNPs were also significant when analyzing the
asymptomatic infection versus never_malaria groups: rs909253 -
LTA+252 (OR: 3.508, 95% CI: 1.641–7.502; P=0.0007),
rs1800896 - IL10-1082 (OR: 0.280, 95% CI: 0.142–0.552;
P=0.0001), rs3024500 (OR: 0.418, 95% CI:0.236–0.739;
P=0.0017) and rs1800890 - IL10-3533 (OR: 0.280, 95% CI:
Table 1. Baseline and clinical characteristics of the studied population.
Controls (n=113) malaria cases (n=535)
n (median) % (range) n (median) % (range)
Age (years) (19.0) (3.0–72.0) (18.0) (1.0–88.0)
Gender (male) 31 28.4 283 53.7
Number of individuals
Barcelos 102 90.3 494 92.3
Santa Izabel do Rio Negro 11 9.7 41 7.7
Clinical phenotype of malaria cases
Previous history of mild malaria* 300 56,1
Clinical Malaria 22 113 21,1
Asymptomatic infection 22 122 22,8
Parasites in clinical malaria or
asymptomatic infection
P. falciparum 22 106 45.7
P. vivax 22 110 47.5
both 22 16 6.9
*these individuals were not infected at the moment of blood collection but recorded as having previously mild malaria; Controls were healthy individuals with no
history of previous malaria; For some statistical analysis we have grouped clinical malaria patients, asymptomatic infected individuals and individuals with previous
history of malaria (any_malaria group) and clinical malaria patients previous history of mild malaria (clinical_malaria group).
doi:10.1371/journal.pone.0036692.t001
Candidate Malaria SNPs in a Brazilian Population
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(LD) between the three IL10 polymorphisms (minimum pairwise
D’ =0.85). A haplotype analysis of these three polymorphisms
(rs3024500, rs1800896, rs1800890) revealed that those with the
GCT allelic combination (,10% frequency in population) were at
a lower risk of any form of malaria (OR: 0.40–0.63, 95% CI: 0.2–
0.9) when compared to the common ATA combination (.83%
frequency in population; see Table 3).
Analysis of the four polymorphisms on the X-chromosome
revealed no significant associations (Table S2). These included the
G6PD+202A allele, also referred to as A
2, which is a deficiency
surrogate that occurs at a low frequency in our population (,3%).
Two other candidate polymorphisms with a strong presence in the
malaria literature, type HbS and B blood groups, were present at
low frequencies in our population (,4%) and, therefore, lacked
the power to detect an association (P.0.03; see Table 4) in this
study. It was interesting to note that in our population the null
allele of the Duffy antigen was present at a frequency of ,10%
(Table 4).
There was no evidence of population structure effects from the
two locations on the association analysis. First, the Fst values across
all markers were close to zero (median 0.0009, range 0 to 0.0063;
see Supplementary Table S3 for values). Second, by removing the
data of Santa Isabel do Rio Negro from the analysis, the
association hits were identical, but with a lower precision on the
odds ratio estimates. Supplementary Tables S4, S5, S6, S7 display
data on allele frequencies and tests of association between groups
studied in this work.
Discussion
This genetic association study was designed to correlate the
presence of various host gene polymorphisms within a Brazilian
Amazonian population with the clinical presentation of malaria for
the purpose of identifying candidate genes whose functions could
impact disease progression. The results showed, for the first time,
an association between alleles of CTL4 gene with malaria. Within
the MHC class III region, the SNP (rs2242665) located in the
CTL4 gene, displayed a significant association with reduced risk
for clinical (mild) malaria. This gene encodes for a possible
sodium-dependent transmembrane transport protein involved in
the uptake of choline by cholinergic neurons. As the MHC class III
region has a complex haplotype structure with long-range LD
patterns, this finding could arise from a functional variant in high
linkage with this SNP.
Polymorphic variability in the innate immune response gene
IL-10 also showed a strong haplotype risk association (OR ,0.7
for the GCT haplotype, see Table 3) on both asymptomatic
infection and clinical (mild) malaria. When analysed at the level
of individual SNPs, an association was discovered for those
individuals displaying IL10 - 1082 with a reduced risk for
malaria symptoms. Previous studies in a Kenyan population
Figure 1. Minimum p-values from tests of association for the autosomal SNPs.* any malaria: Any_malaria group (clinical malaria,
asymptomatic infection and previous history of malaria); asym: Asymptomatic group (individuals with asymptomatic infection); malaria:
Clinical_Malaria group (current or previous history of mild malaria); never: never_malaria group (no history of previous malaria); genotypic tests
of dominant, recessive, general, heterozygous advantage, and additive models, adjusted for gender; the dashed line represents a p-value of 0.003.
doi:10.1371/journal.pone.0036692.g001
Candidate Malaria SNPs in a Brazilian Population
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promoter variants (21082A/G (this study), 2819T/C, and
2592A/C), and protection against severe malarial anaemia and
an increased production of IL10 [34]. The absence of
immunoassay data within this study and severe malaria
phenotypes observed in the participants was a limitation to
demonstrating the role of IL10 in mitigating Plasmodium
infections.
Two other associations with cytokines were identified, both
within MHC class III region, that included TNF and the
lymphotoxin alpha (LT-a/LTA) and beta (LT-ß/LTB) genes,
which are closely related. The TNF and LTA genes are implicated
in the host defense and pathogeneses of severe malaria [5,35]. An
intronic SNP in LTA (rs909253) was associated with protection
from clinical (mild) malaria. Previous studies showed no significant
risk associated with LTA in a Sri Lankan population [36] or cohorts
in Kenya and Malawi [11]. These disparities of association could be
due to differences in the genetic background between the Brazilian
population with those of the Sri Lankan and African populations.
In addition, the TNF-376 promoter SNP (rs1800750) was
identified to have an association with clinical malaria (Table 2). An
association was previously found for this SNP with an increased
risk for cerebral malaria in Kenya and Gambia, conferring an
allele-specific binding of the transcription factor OCT-1([37,38];
see [11] for a review). This observation adds support to the current
dogma that the TNF locus is important for malaria pathogenesis.
However, it is necessary to corroborate these findings with a large
scale epidemiological and immunological functional study.
Other cytokine-related findings include one SNP (rs2706384) in
the Interferon Regulatory Factor 1 gene (IRF1), which was
associated with an increased risk for clinical malaria. IRF1 is a
critical mediator of IFN-c activity and is crucial in both innate and
adaptative immune responses against P. falciparum [39]. Our
finding are consistent with a previously reported association
between polymorphisms in the IRF1 and the control of P.
falciparum infection both in healthy adults and children displaying
severe and uncomplicated malaria [40]. Moreover, this gene is
located in the 5q31 region, which has been shown to be associated
with P. falciparum infection levels [32,33].
Finally, a polymorphism was seen in the TLR4 gene
(rs4986790) that was associated with reduced risk for clinical
malaria. Previous studies in an Amazonian population reported no
association between TLR4 and mild malaria [20,22]. However,
the absence of an apparent association may be due to the lower
minor allele frequencies and smaller samples sizes of those studies.
Unlike the results reported here, two studies in Ghana have
revealed frequent polymorphisms at TLR4 that conferred an
increased risk of severe malaria [12] and clinical manifestations of
malaria during pregnancy [13]. The absence of severe malaria in
Brazil could explain the differences in association results.
Together, the genetic data support a role for TLR4 in modulating
the presentation of malaria symptoms.
Overall, this study represents the first association study from an
Amazonian population involving a large number of host genetic
polymorphisms with susceptibility or resistance to Plasmodium
infection and malaria outcomes. To understand which are the real
causal variants, re-sequencing of LTA, TNF and CTL4 genes and
the surrounding MHC class III in a range of populations will be
necessary to assist the design of large scale epidemiological studies.
Previous candidate polymorphisms have arisen mostly from studies
Table 3. Haplotype analysis of IL10 gene.
Comparison Haplotype Hap-score p-value Controls Cases OR LCL UCL
groups Freq. Freq.
Any_malaria Never_malaria GCT 22.697 0.007 0.162 0.097 0.573 0.385 0.852
GCA 21.582 0.114 0.041 0.022 0.457 0.202 1.032
GTA 1.299 0.194 0.005 0.017 3.337 0.449 24.80
ATA 2.363 0.018 0.784 0.849 1.000 22
global-stat =12.459, df =4, P=0.0142
Asymptomatic Never_malaria GCT 22.894 0.004 0.162 0.069 0.406 0.221 0.744
GCA 21.468 0.142 0.041 0.017 0.342 0.101 1.158
ATA 2.846 0.004 0.784 0.887 1.000 22
global-stat =12.127, df =3, P=0.0070
Clinical_Malaria Never_malaria GCT 22.225 0.026 0.162 0.105 0.625 0.416 0.938
GCA 21.380 0.168 0.041 0.024 0.492 0.212 1.138
GTA 1.428 0.153 0.005 0.018 3.887 0.502 30.11
ATA 1.903 0.057 0.784 0.839 1.000 22
global-stat =9.7201, df =4, P=0.0454
Clinical_Malaria Asymptomatic GCT 1.599 0.110 0.069 0.105 1.579 0.914 2.728
GCA 0.578 0.562 0.017 0.024 1.465 0.481 4.457
GTA 0.394 0.694 0.014 0.018 1.306 0.391 4.356
ATA 21.728 0.084 0.887 0.839 1.000 22
global-stat =3.2488, df =4, P=0.5171
Any_malaria group consisted of: clinical malaria, asymptomatic infection and previous history of malaria; Asymptomatic group: asymptomatic infection; Clinical_Malaria
group: clinical mild malaria (current or previous mild malaria); Never_malaria group: no history of malaria: Haplotypes are for rs3024500, rs1800896,and rs1800890; Freq:
frequency; OR: odds ratio; 95% Confidence interval (LCL- UCL); df : degrees of freedom.
doi:10.1371/journal.pone.0036692.t003
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correlation structure between SNPs, the absence of Plasmodium
vivax, endemicity, and disease severity complicate their relevancy
to Amazonian populations. For example, the data analysis from
our study revealed no significant associations for gene polymor-
phisms of the sickle-cell trait, blood-related polymorphisms and
G6PD A
- surrogate, which display inherited innate resistance to
malaria. These results were not unexpected, given that the low
frequencies of these alleles in the Brazilian population together
with the current sample size that restricted the resolving power of
the analysis to detect associations.
The issue of malaria disease association mapping and its
implications for disease management in multiple geographic
locations remains a major challenge confronting the field. The
differences highlighted here and the association of specific SNP
polymorphisms with clinical malaria in the Amazon basin support
the need for additional studies. The results suggest a need for
associations studies with more dense mapping of candidate genes,
especially CTL4 and IL-10, along with other genes from the major
histocompatibility complex region to identify additional functional
variants most relevant for malaria in Amazonian populations.
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